Literature DB >> 25972502

Optimizing adherence to preexposure and postexposure prophylaxis: the need for an integrated biobehavioral approach.

Aaron J Blashill1, Peter P Ehlinger2, Kenneth H Mayer3, Steven A Safren1.   

Abstract

Preexposure prophylaxis (PrEP) and postexposure prophylaxis (PEP) has been shown to be effective in preventing transmission of human immunodeficiency virus (HIV). A dose-response relationship between adherence and HIV transmission is illustrated in the current PrEP literature, and adherence interventions for PrEP may be useful, although currently few effective programs have been developed and tested. There is a paucity of randomized controlled trials testing PEP adherence interventions, and further research is needed. We conclude by proposing the importance of tailoring adherence counseling to address psychosocial factors and mental health stressors that may negatively affect adherence.
© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HIV; PEP; PrEP; adherence; mental health

Mesh：

Substances：

Year:  2015        PMID： 25972502      PMCID： PMC4551106          DOI： 10.1093/cid/civ111

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  33 in total

1.  Optimizing content for pre-exposure prophylaxis (PrEP) counseling for men who have sex with men: Perspectives of PrEP users and high-risk PrEP naïve men.

Authors:  S Wade Taylor; Kenneth H Mayer; Steven M Elsesser; Matthew J Mimiaga; Conall O'Cleirigh; Steven A Safren
Journal:  AIDS Behav       Date:  2014-05

2.  An intervention to support HIV preexposure prophylaxis adherence in HIV-serodiscordant couples in Uganda.

Authors:  Christina Psaros; Jessica E Haberer; Elly Katabira; Allan Ronald; Elioda Tumwesigye; James D Campbell; Jonathan Wangisi; Kenneth Mugwanya; Alex Kintu; Michael Enyakoit; Katherine K Thomas; Deborah Donnell; Meighan Krows; Lara Kidoguchi; Norma Ware; Jared M Baeten; Connie Celum; David R Bangsberg; Steve A Safren
Journal:  J Acquir Immune Defic Syndr       Date:  2014-08-15       Impact factor: 3.731

3.  Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.

Authors:  Robert M Grant; Peter L Anderson; Vanessa McMahan; Albert Liu; K Rivet Amico; Megha Mehrotra; Sybil Hosek; Carlos Mosquera; Martin Casapia; Orlando Montoya; Susan Buchbinder; Valdilea G Veloso; Kenneth Mayer; Suwat Chariyalertsak; Linda-Gail Bekker; Esper G Kallas; Mauro Schechter; Juan Guanira; Lane Bushman; David N Burns; James F Rooney; David V Glidden
Journal:  Lancet Infect Dis       Date:  2014-07-22       Impact factor: 25.071

Review 4.  A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugs.

Authors:  Meredith Camp Binford; Shoshana Y Kahana; Frederick L Altice
Journal:  Curr HIV/AIDS Rep       Date:  2012-12       Impact factor: 5.071

5.  Attitudes and program preferences of African-American urban young adults about pre-exposure prophylaxis (PrEP).

Authors:  Dawn K Smith; Lauren Toledo; Donna Jo Smith; Mary Anne Adams; Richard Rothenberg
Journal:  AIDS Educ Prev       Date:  2012-10

6.  The psychological cost of anticipating HIV stigma for HIV-negative gay and bisexual men.

Authors:  Tyrel J Starks; H Jonathon Rendina; Aaron S Breslow; Jeffrey T Parsons; Sarit A Golub
Journal:  AIDS Behav       Date:  2013-10

Review 7.  Adherence to post-exposure prophylaxis for non-forcible sexual exposure to HIV: a systematic review and meta-analysis.

Authors:  Catherine E Oldenburg; Till Bärnighausen; Guy Harling; Matthew J Mimiaga; Kenneth H Mayer
Journal:  AIDS Behav       Date:  2014-02

8.  Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.

Authors:  Kachit Choopanya; Michael Martin; Pravan Suntharasamai; Udomsak Sangkum; Philip A Mock; Manoj Leethochawalit; Sithisat Chiamwongpaet; Praphan Kitisin; Pitinan Natrujirote; Somyot Kittimunkong; Rutt Chuachoowong; Roman J Gvetadze; Janet M McNicholl; Lynn A Paxton; Marcel E Curlin; Craig W Hendrix; Suphak Vanichseni
Journal:  Lancet       Date:  2013-06-13       Impact factor: 79.321

Review 9.  Adherence support approaches in biomedical HIV prevention trials: experiences, insights and future directions from four multisite prevention trials.

Authors:  K Rivet Amico; Leila E Mansoor; Amy Corneli; Kristine Torjesen; Ariane van der Straten
Journal:  AIDS Behav       Date:  2013-07

10.  Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa.

Authors:  Jessica E Haberer; Jared M Baeten; James Campbell; Jonathan Wangisi; Elly Katabira; Allan Ronald; Elioda Tumwesigye; Christina Psaros; Steven A Safren; Norma C Ware; Katherine K Thomas; Deborah Donnell; Meighan Krows; Lara Kidoguchi; Connie Celum; David R Bangsberg
Journal:  PLoS Med       Date:  2013-09-10       Impact factor: 11.069
View more
  7 in total

1.  Syndemics and the PrEP Cascade: Results from a Sample of Young Latino Men Who Have Sex with Men.

Authors:  Aaron J Blashill; John P Brady; Benjamin M Rooney; Carlos E Rodriguez-Diaz; Keith J Horvath; Jill Blumenthal; Sheldon Morris; David J Moore; Steven A Safren
Journal:  Arch Sex Behav       Date:  2019-10-07

2.  Continuing Links Between Substance Use and HIV Highlight the Importance of Nursing Roles.

Authors:  Sherry Deren; Madeline Naegle; Holly Hagan; Danielle C Ompad
Journal:  J Assoc Nurses AIDS Care       Date:  2017-03-24       Impact factor: 1.354

3.  Commentary: the value of PrEP for people who inject drugs.

Authors:  Rosalind L Coleman; Susie McLean
Journal:  J Int AIDS Soc       Date:  2016-10-18       Impact factor: 5.396

4.  Skating on thin ice: stimulant use and sub-optimal adherence to HIV pre-exposure prophylaxis.

Authors:  J Carlo Hojilla; David Vlahov; David V Glidden; K Rivet Amico; Megha Mehrotra; Robert Hance; Robert M Grant; Adam W Carrico
Journal:  J Int AIDS Soc       Date:  2018-03       Impact factor: 5.396

5.  Persistence on HIV preexposure prophylaxis medication over a 2-year period among a national sample of 7148 PrEP users, United States, 2015 to 2017.

Authors:  Kelsey C Coy; Ronald J Hazen; Heather S Kirkham; Ambrose Delpino; Aaron J Siegler
Journal:  J Int AIDS Soc       Date:  2019-02       Impact factor: 5.396

Review 6.  Intervening for HIV prevention and mental health: a review of global literature.

Authors:  Pamela Y Collins; Jennifer Velloza; Tessa Concepcion; Linda Oseso; Lydia Chwastiak; Christopher G Kemp; Jane Simoni; Bradley H Wagenaar
Journal:  J Int AIDS Soc       Date:  2021-06       Impact factor: 5.396

7.  Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial.

Authors:  Luis Sagaon-Teyssier; Marie Suzan-Monti; Baptiste Demoulin; Catherine Capitant; Nicolas Lorente; Marie Préau; Marion Mora; Daniela Rojas Castro; Christian Chidiac; Julie Chas; Laurence Meyer; Jean-Michel Molina; Bruno Spire
Journal:  AIDS Care       Date:  2016-02-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.